Objective assessment of compliance with treatments in acne

British Journal of Dermatology

Volumn 152, Issue 5, 2005, Pages 1015-1021

  Zaghloul, Sameh S ^a   Cunliffe, W J ^a   Goodfield, M J D ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Acne; Compliance; Medication adherence; Psychosocial determinants; Quality of life; Treatment distribution

Indexed keywords

ISOTRETINOIN;

ACNE VULGARIS; ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHILD; CIGARETTE SMOKING; DISEASE SEVERITY; EMPLOYMENT; FEMALE; GENDER; HUMAN; HUMAN RELATION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PATIENT COMPLIANCE; PREPUBERTY; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SELF ESTEEM; SOCIAL ASPECT; TREATMENT FAILURE;

ACNE VULGARIS; ADOLESCENT; ADULT; AGE FACTORS; ALCOHOL DRINKING; CHILD; EMPLOYMENT; FEMALE; HUMANS; ISOTRETINOIN; KERATOLYTIC AGENTS; MALE; MARITAL STATUS; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PATIENT COMPLIANCE; PRESCRIPTIONS, DRUG; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEX FACTORS; SMOKING;

EID: 18944375838     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06357.x     Document Type: Article

References (40)

1. Koo J. The psychosocial impact of acne: patients' perceptions. J Am Acad Dermatol 1995; 32:526-30.
2. Shuster S, Fisher GH, Harris E, Binnell D. The effect of skin disease on self-image. Br J Dermatol 1978; 99 (Suppl. 16): 18-9.
3. Rubinow DR, Peck GL, Squillace KM, Gantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987; 17:25-32.
4. Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol 1997; 137:246-50.
5. Cunliffe WJ. Acne and unemployment. Br J Dermatol 1986; 115:386.
6. Wu SF, Kinder BN, Trunnell TN, Fulton JE. Role of anxiety and anger in acne patients: a relationship with severity of the disorder. J Am Acad Dermatol 1988; 18:325-33.
7. Newton JN, Mallon E, Klassen A et al. The effectiveness of acne treatment: an assessment of the outcome of therapy. Br J Dermatol 1997; 137:563-7.
8. Layton AM. The psychosocial impact of acne. Dermatology 2000; 2:40-3.
9. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139:846-50.
10. Zaghloul SS, Goodfield MJD. Objective assessment of compliance with treatments in psoriasis. Arch Dermatol 2004; 140:408-14.
11. Haynes RB. Introduction. In: Compliance in Health Care (Haynes RB, Sackett DL, Taylor DW, eds). Baltimore: Johns Hopkins University Press, 1975; 1-6.
12. Haynes RB. A critical review of the determinants of patient compliance with therapeutic regimens. In: Compliance in Health Care (Haynes RB, Sackett DL, Taylor DW, eds). Baltimore: Johns Hopkins University Press, 1975; 26-39.
13. Gordis L. Methodologic issues in the measurement of patient compliance. In: Compliance in Health Care (Haynes RB, Sackett DL, Taylor DW, eds). Baltimore: Johns Hopkins University Press, 1975; 51-66.
14. Fawcett J. Compliance: definitions and key issues. J Clin Psychiatry 1995; 56:4-8.
15. Goldsmith CH. A measure of compliance. In: Compliance in Health Care (Haynes RB, Sackett DL, Taylor DW, eds). Baltimore: Johns Hopkins University Press, 1975; 137.
16. Zaghloul SS. Compliance in Skin Disease. MD Thesis, University of Leeds, 2002.
17. Zaghloul SS, Gonzalez M, Judodihardjo H, Finlay AY. In psoriasis, the greater the disability, the poorer the topical treatment compliance. Br J Dermatol 1999; 141 (Suppl. 55): 48 (Abstract).
18. Long CC, Finlay AY. The rule of hand: 4 hand areas = 2 FTU = 1 g. Arch Dermatol 1992; 128:1129-30.
19. Mufleh L, Gonzalez M, Judodihardjo H, Finlay AY. Compliance is high in patients taking oral isotretinoin for acne. Br J Dermatol 1999; 141 (Suppl. 55): 87 (Abstract).
20. Zaghloul SS, Cunliffe WJ, Goodfield MJD. Compliance in psoriasis is highly correlated with psychological well-being. Br J Dermatol 2001; 145 (Suppl. 59): 41 (Abstract).
21. Zaghloul SS, Goodfield MJD. Compliance in psoriasis: patients' self reporting and factors affecting medication adherence. Br J Dermatol 2002; 147 (Suppl. 62): 43-4 (Abstract).
22. McKenna KE, Stern RS. The outcomes movement and new measures of the severity of psoriasis. J Am Acad Dermatol 1996; 34:534-8.
23. Relman AS. Assessment and accountability: the third revolution in medical care. N Engl J Med 1988; 319:1 220-2.
24. Brook RH, Davies-Avery A, Greenfield S et al. Assessing the quality of care using outcome methods: an overview of the method. Med Care 1977; 15 (Suppl. 19): 5-15.
25. Bullinger M, Hasford J. Evaluating quality of life measures for German clinical trials. Control Clin Trials 1991; 12:591-105.
26. Schipper H, Clinch JJ, Olweny CHLM. Quality of life studies: definition and conceptual issues. In: Quality of Life and Pharmacoeconomics in Clinical Trials (Spilker B, ed.). Philadelphia: Lippincott-Raven, 1996; 11-24.
27. Garratt AM, Ruta DA, Abdalla MI et al. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ 1993; 306:1440-4.
28. Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol 1992; 17:1-3.
29. Finlay AY, Kahn GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19:210-6.
30. Patel SC, Spaeth GL. Compliance in patients prescribed eye drops for glaucoma. Ophthalmic Surg 1995; 26:233-6.
31. Finlay AY, Long CC. The finger-tip unit-a new practical measure. Clin Exp Dermatol 1991; 16:444-7.
32. Cunliffe WJ, O'Brien SC, Lewis JB. The Leeds revised acne-grading system. J Dermatol Treat 1998; 9:215-20.
33. Horowitz RL, Horowitz SM. Adherence to treatment and health outcomes. Arch Int Med 1993; 153:1863-8.
34. Linn MW, Klett CJ, Cafey EM Jr. Relapse of psychiatric patients in foster care. Am J Psychiatry 1982; 139:778-83.
35. Green JH. Frequent rehospitalization and noncompliance with treatment. Hosp Community Psychiatry 1988; 39:963-6.
36. Caton CL, Koh SP, Fleiss JL et al. Rehospitalization in chronic schizophrenia. J Nerv Ment Dis 1985; 173:139-48.
37. Coffield KE, Buckalew LW. A study of colour preference for drugs and implications for compliance and drug taking. J Alcohol Drug Educ 1988; 34:28-36.
38. Roberson MHB. The meaning of compliance: patient perspectives. Qual Health Rev 1992; 2:7-26.
39. Conway A. Adherence and compliance in the management of asthma: 1. Br J Nurs 1998; 7:1313-5.
40. Mallon E, Newton JN, Klassen A et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999; 140:672-6.